PainNCT02789969
Pain Medications in Children Undergoing Strabismus Surgery
A study testing Hydromorphone and Fentanyl in people with Pain and Nausea, run by St. Louis Children's Hospital at 1 site in United States.
Trial summary
Every year over 1,000 children undergo eye muscle surgery provided by physicians at this institution. For many of these children this is not and will not be the only surgical procedure for eye muscle correction. All of these children will experience differing degrees of postoperative pain. Read more about this study
- Who is it for?
- Ages 3 to 10 years
- What is being tested?
- Hydromorphone and Fentanyl
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 128 participants
- Where
- 1 siteUnited States
- Study dates
- Apr 2016to Apr 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 3 to 10 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- ages 3 to 10 years old having strabismus surgery for the first time, a repeated strabismus surgery, or an eye examination for strabismus under anesthesia;
- evaluated as an American Society of Anesthesiologists Physical Status (ASAPS) classification Class 1 or 2
- the caregiver should be present in the hospital
- the child and caregiver must be English speaking.
Who cannot join
- evaluated as an ASAPS Class 3 or 4
- non-English speaking children or parents
- additional surgery performed at the same time
- documented behavioral disabilities
- prior participation in the study.
Trial locations and contacts
1 site in 1 country.
United States1 site, 1 recruiting
- Recruiting
St. Louis Children's Hospital
St Louis, Missouri, 63110
Lisa Steurer, PhD(c), 314-454-4528, lmi8177@bjc.org
About this study
Official title: A Randomized Controlled Trial to Compare Pain Medications in Children Undergoing Strabismus Surgery
Every year over 1,000 children undergo eye muscle surgery provided by physicians at this institution. For many of these children this is not and will not be the only surgical procedure for eye muscle correction. All of these children will experience differing degrees of postoperative pain. The pain associated with strabismus surgery is due to the manipulation in the conjunctival area and further handling of Tenon's capsule, sclera and the stretching of the eye muscle . Research has demonstrated that repeated painful procedures result in increased anxiety and increased pain.
Previous studies have demonstrated that children experiencing preoperative anxiety are more likely to have increased postoperative pain . This increased preoperative anxiety may also contribute to sleep difficulties and increased analgesic consumption. Depending on the age of the child, different methods are used to reduce anxiety such as distraction, child life services, or anti-anxiolytic agents.
In addition to pain, children undergoing strabismus surgery frequently experience postoperative nausea and vomiting (PONV).This increased incidence of nausea and vomiting is thought to be related to the use of opiates for pain control. Short acting opiates are used preferentially at this hospital in the belief that this reduces recovery issues of sedation and PONV. Preliminary data, however, suggests no difference in recovery outcomes for fentanyl versus hydromorphone. The purpose of this study is to investigate the optimal analgesia to create a standardized approach for pain management in pediatric patients undergoing surgery for strabismus.
Read the detailed description
Research Design This is a randomized clinical trial with masked assessment, comparing recovery indices for patients receiving longer acting versus shorter acting opiate analgesia using hydromorphone or fentanyl as intraoperative analgesics. An otherwise standardized anesthetic and analgesic regimen will be utilized, as consistent with routine care at the research institution.
Sample and Setting Patients included will be children age 3 through 10 years scheduled for strabismus surgery. The procedure may also include scheduled exam under anesthesia (EUA) of the eyes, but any other surgical procedure in conjunction with strabismus will be excluded from enrollment. Review of anesthesia records shows that 480 patients met inclusion criteria for the preceding 12 months. The primary outcome measure is pain as measured by the revised Faces, Legs, Anxiety, Cry \& Consolability scale (rFLACC). Based on previous pilot work, the investigators expect pain scores to have a mean of five and a standard deviation of two. The goal is to detect a change of one point in rFLACC scores, which the investigators believe would be clinically significant. With alpha of 0.05 and power of 0.80, the investigators would need 64 patients in each arm for a one point decrease in rFLACC scores to be statistically significant. The investigators expect that ten percent of patients will have to be dropped because of missing data, so the investigators are proposing to enroll 71 patients in each arm (142 patients total) in order to have data for 64 patients in the analyses.
Inclusion criteria will be 1) children ages 3 to 10 years old having strabismus surgery for the first time, a repeated strabismus surgery, or an eye examination for strabismus under anesthesia; 2) the child has to be evaluated as an American Society of Anesthesiologists Physical Status (ASAPS) classification Class 1 or 2; 3) the caregiver should be present in the hospital; and 4) the child and caregiver must be English speaking. Exclusion criteria will include 1) children evaluated as an ASAPS Class 3 or 4; non-English speaking children or parents; 3) additional surgery performed at the same time; 4) children with documented behavioral disabilities; 5) prior participation in the study.
Tools A researcher developed demographic questionnaire will be used to collect information from a parent that includes patient age, gender, previous surgery, any medication allergies, and primary caregiver. The Amsterdam Preoperative Anxiety and Information Scale (APAIS) will be used to assess parent feelings of anxiety in the preoperative phase. The APAIS is short 6-item questionnaire with acceptable reliability with Cronbach's alpha greater than or equal to 70 and correlated highly (0.74) with the widely used State Trait Anxiety Scale. Because of its length, the APAIS can be quickly administered to parents of children undergoing surgery in order to assess parental preoperative anxiety . The measure will be completed on all parent participants after consent is obtained. The tool takes approximately 1-2 minutes to score.
For evaluating anxiety in children the Modified Anxiety Scale (mYPAS) will be used. The mYPAS is frequently used to measure anxiety prior to induction and has demonstrated both inter and intra-rater reliability (using k statistics) ranging from 0.63 - 0.90 and acceptable reliability (p = 0.01, r = 0.79) The tool can be administered in less than one minute, is reliable in children ages 2-12 years, and uses five areas (activity, vocalization, expression, arousal, and interaction) to rate preoperative anxiety.
In the Post Anesthesia Care Unit (PACU) and in Same Day Surgery (SDS), nurses will use the rFLACC scale to measure pain. The tool has established reliability and validity and is used throughout the hospital to assess pain in children unable to verbalize pain. The interrater reliability revealed intra-class correlation coefficients ranging from 0.76-0.90. Criterion validity (p=0.65-0.87) was supported by correlations between parent and child scores. For pain assessment at 24 hours post operatively, parents will be asked to rate the intensity of the subject's pain on a scale of 0 (no pain) to 10 (worst pain imaginable). The Numeric Pain Rating Scale developed by McCaffery is a widely used instrument in the clinical setting with previously established reliability and validity. The instrument is scored as 0 = no pain; 1-3 = mild pain; 4-6 = moderate pain; 7-10 = severe pain.
Procedure IRB approval will be secured prior to recruitment. As is standard care, subjects will be contacted by telephone in the days prior to the scheduled surgery. During that contact, subjects will be informed of the offer to participate in this study, and be provided with a brief description of the protocol. On the day of surgery, a researcher will visit interested subjects and provide a complete explanation and written consent document.
Consenting subjects will then be evaluated with the Amsterdam Preoperative Anxiety Scale, and the researcher will complete the YPAS-m scale prior to surgery. At the time consent is obtained, subjects will also be asked to complete a brief demographic data form.
After surgery, the nurse will evaluate the patient's pain using rFLACC scale on arrival to the Post Anesthesia Care Unit (PACU) and every fifteen minutes during the patient's stay. After transferring from PACU to SDS, the nurse will continue to evaluate pain using the same scale on arrival and before discharge. The nurse will document the patient's level of pain and need for any additional pain medication. To help ensure study fidelity in regard to pain assessment, all nurses will be given a refresher class on use of the rFLACC. After discharge, the patient will receive a telephone call 24 hours after surgery to evaluate post-operative nausea and vomiting and the level of pain at home.
Patients will receive a standard anesthetic consisting of midazolam premedication when indicated for anticipated separation anxiety, then sevoflurane inhalation utilizing nitrous oxide during mask induction, but no nitrous oxide during maintenance anesthesia. Analgesia and PONV prophylaxis is standardized as acetaminophen 15 mg/kg oral preoperative (maximum 650), followed by ketorolac 0.5 mg/kg IV (maximum 30), ondansetron 0.15 mg/kg IV, and dexamethasone 0.15 mg/kg IV. Airway maintenance will be with a laryngeal mask, and emergence conducted in the operating room with the aim of a responsive patient at time of departure from the operating room.
Patients will be randomized to either hydromorphone or fentanyl once in the operating room by opening a sealed protocol envelope. The anesthesiologist will fractionate the total dose opiate administered as the clinical situation warrants to preserve spontaneous breathing. The anesthesiologist will titrate the same drug as required during the first 15 minutes in the recovery room to ensure that immediate analgesic goals are met.
- Being tested
- Hydromorphone, Fentanyl
- Medical subject headings
- Pain, Nausea
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
HydromorphoneDrug
Also called Dilaudid
Hydromorphone 15mcg/kg IV
FentanylDrug
Also called Sublimaze
Fentanyl 1.5mcg/kg IV
| Study group | Role | What they receive |
|---|---|---|
| Hydromorphone 15mcg/kg IV | Experimental | Patient randomly assigned to hydromorphone Receives: Drug: Hydromorphone |
| Fentanyl 1.5 mcg/kg IV | Experimental | Patient randomly assigned to fentanyl Receives: Drug: Fentanyl |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in pain measured by the rFLACC scale
Measured: every 15 minutes for 2 hours and 24 hours after discharge
Secondary outcomes (2)
nausea measured by self-report
Measured: every 15 minutes for 2 hours and 24 hours after discharge
Parental anxiety measured by Amsterdam Preoperative Anxiety and Information Scale
patient anxiety
Measured: 1 time preoperatively 1 hour before surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jun 2016 (estimated)
- Study startApr 2016
- Primary completionMar 2017 (estimated)
- Study completionApr 2017 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (9)Papers the sponsor has linked to this study.
- Other trials for PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 128 participants (estimated)
Sponsor and investigators
- Lead sponsor
- St. Louis Children's Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Hasima Hajdini, BSN, Principal investigator, St. Louis Children's HospitalCharles Schrock, MD, Study director, Washington University School of Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02789969
- Sponsor's protocol ID
- 201602156
- Status last verified
- Jun 2016
- First submitted
- 23 May 2016
- Last updated
- 3 Jun 2016
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Publications
Noel M, McMurtry CM, Chambers CT, McGrath PJ. Children's memory for painful procedures: the relationship of pain intensity, anxiety, and adult behaviors to subsequent recall. J Pediatr Psychol. 2010 Jul;35(6):626-36. doi: 10.1093/jpepsy/jsp096. Epub 2009 Nov 4.
PubMed 19889718Bakr RH, Abdelaziz HM. SUBTENON BUPIVACAINE INJECTION FOR POSTOPERATIVE PAIN RELIEF FOLLOWING PEDIATRIC STRABISMUS SURGERY: A RANDOMIZED CONTROLLED DOUBLE BLIND TRIAL. Middle East J Anaesthesiol. 2015 Feb;23(1):91-9.
PubMed 26121900Kain ZN, Mayes LC, Caldwell-Andrews AA, Karas DE, McClain BC. Preoperative anxiety, postoperative pain, and behavioral recovery in young children undergoing surgery. Pediatrics. 2006 Aug;118(2):651-8. doi: 10.1542/peds.2005-2920.
PubMed 16882820Chieng YJ, Chan WC, Klainin-Yobas P, He HG. Perioperative anxiety and postoperative pain in children and adolescents undergoing elective surgical procedures: a quantitative systematic review. J Adv Nurs. 2014 Feb;70(2):243-55. doi: 10.1111/jan.12205. Epub 2013 Jul 19.
PubMed 23865442Chieng YJ, Chan WC, Liam JL, Klainin-Yobas P, Wang W, He HG. Exploring influencing factors of postoperative pain in school-age children undergoing elective surgery. J Spec Pediatr Nurs. 2013 Jul;18(3):243-52. doi: 10.1111/jspn.12030. Epub 2013 Apr 23.
PubMed 23822848Brasher C, Gafsous B, Dugue S, Thiollier A, Kinderf J, Nivoche Y, Grace R, Dahmani S. Postoperative pain management in children and infants: an update. Paediatr Drugs. 2014 Apr;16(2):129-40. doi: 10.1007/s40272-013-0062-0.
PubMed 24407716He HG, Zhu L, Chan SW, Klainin-Yobas P, Wang W. The effectiveness of therapeutic play intervention in reducing perioperative anxiety, negative behaviors, and postoperative pain in children undergoing elective surgery: a systematic review. Pain Manag Nurs. 2015 Jun;16(3):425-39. doi: 10.1016/j.pmn.2014.08.011.
PubMed 26025800He HG, Zhu L, Li HC, Wang W, Vehvilainen-Julkunen K, Chan SW. A randomized controlled trial of the effectiveness of a therapeutic play intervention on outcomes of children undergoing inpatient elective surgery: study protocol. J Adv Nurs. 2014 Feb;70(2):431-42. doi: 10.1111/jan.12234. Epub 2013 Aug 29.
PubMed 23991679Chhabra A, Pandey R, Khandelwal M, Subramaniam R, Gupta S. Anesthetic techniques and postoperative emesis in pediatric strabismus surgery. Reg Anesth Pain Med. 2005 Jan-Feb;30(1):43-7. doi: 10.1016/j.rapm.2004.08.023.
PubMed 15690267
Study at a glance
From the registry record, last updated by the sponsor on 3 Jun 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Randomized Controlled Trial to Compare Pain Medications in Children Undergoing Strabismus Surgery
- ClinicalTrials.gov ID
- NCT02789969
- Acronym / sponsor ID
- 201602156
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 128 participants (estimated)
- Lead sponsor
- St. Louis Children's HospitalUniversity, hospital or other
- Study start
- Apr 2016
- Primary completion
- Mar 2017 (estimated)
- Study completion
- Apr 2017 (estimated)
- First posted
- 3 Jun 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Every year over 1,000 children undergo eye muscle surgery provided by physicians at this institution. For many of these children this is not and will not be the only surgical procedure for eye muscle correction. All of these children will experience differing degrees of postoperative pain. The pain associated with strabismus surgery is due to the manipulation in the conjunctival area and further handling of Tenon's capsule, sclera and the stretching of the eye muscle . Research has demonstrated that repeated painful procedures result in increased anxiety and increased pain.
Previous studies have demonstrated that children experiencing preoperative anxiety are more likely to have increased postoperative pain . This increased preoperative anxiety may also contribute to sleep difficulties and increased analgesic consumption. Depending on the age of the child, different methods are used to reduce anxiety such as distraction, child life services, or anti-anxiolytic agents.
In addition to pain, children undergoing strabismus surgery frequently experience postoperative nausea and vomiting (PONV).This increased incidence of nausea and vomiting is thought to be related to the use of opiates for pain control. Short acting opiates are used preferentially at this hospital in the belief that this reduces recovery issues of sedation and PONV. Preliminary data, however, suggests no difference in recovery outcomes for fentanyl versus hydromorphone. The purpose of this study is to investigate the optimal analgesia to create a standardized approach for pain management in pediatric patients undergoing surgery for strabismus.
Detailed description
Research Design This is a randomized clinical trial with masked assessment, comparing recovery indices for patients receiving longer acting versus shorter acting opiate analgesia using hydromorphone or fentanyl as intraoperative analgesics. An otherwise standardized anesthetic and analgesic regimen will be utilized, as consistent with routine care at the research institution.
Sample and Setting Patients included will be children age 3 through 10 years scheduled for strabismus surgery. The procedure may also include scheduled exam under anesthesia (EUA) of the eyes, but any other surgical procedure in conjunction with strabismus will be excluded from enrollment. Review of anesthesia records shows that 480 patients met inclusion criteria for the preceding 12 months. The primary outcome measure is pain as measured by the revised Faces, Legs, Anxiety, Cry \& Consolability scale (rFLACC). Based on previous pilot work, the investigators expect pain scores to have a mean of five and a standard deviation of two. The goal is to detect a change of one point in rFLACC scores, which the investigators believe would be clinically significant. With alpha of 0.05 and power of 0.80, the investigators would need 64 patients in each arm for a one point decrease in rFLACC scores to be statistically significant. The investigators expect that ten percent of patients will have to be dropped because of missing data, so the investigators are proposing to enroll 71 patients in each arm (142 patients total) in order to have data for 64 patients in the analyses.
Inclusion criteria will be 1) children ages 3 to 10 years old having strabismus surgery for the first time, a repeated strabismus surgery, or an eye examination for strabismus under anesthesia; 2) the child has to be evaluated as an American Society of Anesthesiologists Physical Status (ASAPS) classification Class 1 or 2; 3) the caregiver should be present in the hospital; and 4) the child and caregiver must be English speaking. Exclusion criteria will include 1) children evaluated as an ASAPS Class 3 or 4; non-English speaking children or parents; 3) additional surgery performed at the same time; 4) children with documented behavioral disabilities; 5) prior participation in the study.
Tools A researcher developed demographic questionnaire will be used to collect information from a parent that includes patient age, gender, previous surgery, any medication allergies, and primary caregiver. The Amsterdam Preoperative Anxiety and Information Scale (APAIS) will be used to assess parent feelings of anxiety in the preoperative phase. The APAIS is short 6-item questionnaire with acceptable reliability with Cronbach's alpha greater than or equal to 70 and correlated highly (0.74) with the widely used State Trait Anxiety Scale. Because of its length, the APAIS can be quickly administered to parents of children undergoing surgery in order to assess parental preoperative anxiety . The measure will be completed on all parent participants after consent is obtained. The tool takes approximately 1-2 minutes to score.
For evaluating anxiety in children the Modified Anxiety Scale (mYPAS) will be used. The mYPAS is frequently used to measure anxiety prior to induction and has demonstrated both inter and intra-rater reliability (using k statistics) ranging from 0.63 - 0.90 and acceptable reliability (p = 0.01, r = 0.79) The tool can be administered in less than one minute, is reliable in children ages 2-12 years, and uses five areas (activity, vocalization, expression, arousal, and interaction) to rate preoperative anxiety.
In the Post Anesthesia Care Unit (PACU) and in Same Day Surgery (SDS), nurses will use the rFLACC scale to measure pain. The tool has established reliability and validity and is used throughout the hospital to assess pain in children unable to verbalize pain. The interrater reliability revealed intra-class correlation coefficients ranging from 0.76-0.90. Criterion validity (p=0.65-0.87) was supported by correlations between parent and child scores. For pain assessment at 24 hours post operatively, parents will be asked to rate the intensity of the subject's pain on a scale of 0 (no pain) to 10 (worst pain imaginable). The Numeric Pain Rating Scale developed by McCaffery is a widely used instrument in the clinical setting with previously established reliability and validity. The instrument is scored as 0 = no pain; 1-3 = mild pain; 4-6 = moderate pain; 7-10 = severe pain.
Procedure IRB approval will be secured prior to recruitment. As is standard care, subjects will be contacted by telephone in the days prior to the scheduled surgery. During that contact, subjects will be informed of the offer to participate in this study, and be provided with a brief description of the protocol. On the day of surgery, a researcher will visit interested subjects and provide a complete explanation and written consent document.
Consenting subjects will then be evaluated with the Amsterdam Preoperative Anxiety Scale, and the researcher will complete the YPAS-m scale prior to surgery. At the time consent is obtained, subjects will also be asked to complete a brief demographic data form.
After surgery, the nurse will evaluate the patient's pain using rFLACC scale on arrival to the Post Anesthesia Care Unit (PACU) and every fifteen minutes during the patient's stay. After transferring from PACU to SDS, the nurse will continue to evaluate pain using the same scale on arrival and before discharge. The nurse will document the patient's level of pain and need for any additional pain medication. To help ensure study fidelity in regard to pain assessment, all nurses will be given a refresher class on use of the rFLACC. After discharge, the patient will receive a telephone call 24 hours after surgery to evaluate post-operative nausea and vomiting and the level of pain at home.
Patients will receive a standard anesthetic consisting of midazolam premedication when indicated for anticipated separation anxiety, then sevoflurane inhalation utilizing nitrous oxide during mask induction, but no nitrous oxide during maintenance anesthesia. Analgesia and PONV prophylaxis is standardized as acetaminophen 15 mg/kg oral preoperative (maximum 650), followed by ketorolac 0.5 mg/kg IV (maximum 30), ondansetron 0.15 mg/kg IV, and dexamethasone 0.15 mg/kg IV. Airway maintenance will be with a laryngeal mask, and emergence conducted in the operating room with the aim of a responsive patient at time of departure from the operating room.
Patients will be randomized to either hydromorphone or fentanyl once in the operating room by opening a sealed protocol envelope. The anesthesiologist will fractionate the total dose opiate administered as the clinical situation warrants to preserve spontaneous breathing. The anesthesiologist will titrate the same drug as required during the first 15 minutes in the recovery room to ensure that immediate analgesic goals are met.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Hydromorphone 15mcg/kg IV | Experimental | Drug: HydromorphonePatient randomly assigned to hydromorphone |
| Fentanyl 1.5 mcg/kg IV | Experimental | Drug: FentanylPatient randomly assigned to fentanyl |
Who may qualify
- Ages
- 3 to 10 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (4 listed)
- ages 3 to 10 years old having strabismus surgery for the first time, a repeated strabismus surgery, or an eye examination for strabismus under anesthesia;
- evaluated as an American Society of Anesthesiologists Physical Status (ASAPS) classification Class 1 or 2
- the caregiver should be present in the hospital
- the child and caregiver must be English speaking.
Key exclusion criteria (5 listed)
- evaluated as an ASAPS Class 3 or 4
- non-English speaking children or parents
- additional surgery performed at the same time
- documented behavioral disabilities
- prior participation in the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| HydromorphoneAlso: DilaudidHydromorphone 15mcg/kg IV | Drug | Hydromorphone 15mcg/kg IV |
| FentanylAlso: SublimazeFentanyl 1.5mcg/kg IV | Drug | Fentanyl 1.5 mcg/kg IV |
Primary outcome
Change in pain measured by the rFLACC scale
Time frame: every 15 minutes for 2 hours and 24 hours after discharge
2 secondary outcomes
nausea measured by self-report
Time frame: every 15 minutes for 2 hours and 24 hours after discharge
Parental anxiety measured by Amsterdam Preoperative Anxiety and Information Scale
Time frame: 1 time preoperatively 1 hour before surgery
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Jun 2016.
- Background: PubMed 19889718Noel M, McMurtry CM, Chambers CT, McGrath PJ. Children's memory for painful procedures: the relationship of pain intensity, anxiety, and adult behaviors to subsequent recall. J Pediatr Psychol. 2010 Jul;35(6):626-36. doi: 10.1093/jpepsy/jsp096. Epub 2009 Nov 4.
- Background: PubMed 26121900Bakr RH, Abdelaziz HM. SUBTENON BUPIVACAINE INJECTION FOR POSTOPERATIVE PAIN RELIEF FOLLOWING PEDIATRIC STRABISMUS SURGERY: A RANDOMIZED CONTROLLED DOUBLE BLIND TRIAL. Middle East J Anaesthesiol. 2015 Feb;23(1):91-9.
- Background: PubMed 16882820Kain ZN, Mayes LC, Caldwell-Andrews AA, Karas DE, McClain BC. Preoperative anxiety, postoperative pain, and behavioral recovery in young children undergoing surgery. Pediatrics. 2006 Aug;118(2):651-8. doi: 10.1542/peds.2005-2920.
- Background: PubMed 23865442Chieng YJ, Chan WC, Klainin-Yobas P, He HG. Perioperative anxiety and postoperative pain in children and adolescents undergoing elective surgical procedures: a quantitative systematic review. J Adv Nurs. 2014 Feb;70(2):243-55. doi: 10.1111/jan.12205. Epub 2013 Jul 19.
- Background: PubMed 23822848Chieng YJ, Chan WC, Liam JL, Klainin-Yobas P, Wang W, He HG. Exploring influencing factors of postoperative pain in school-age children undergoing elective surgery. J Spec Pediatr Nurs. 2013 Jul;18(3):243-52. doi: 10.1111/jspn.12030. Epub 2013 Apr 23.
- Background: PubMed 24407716Brasher C, Gafsous B, Dugue S, Thiollier A, Kinderf J, Nivoche Y, Grace R, Dahmani S. Postoperative pain management in children and infants: an update. Paediatr Drugs. 2014 Apr;16(2):129-40. doi: 10.1007/s40272-013-0062-0.
- Background: PubMed 26025800He HG, Zhu L, Chan SW, Klainin-Yobas P, Wang W. The effectiveness of therapeutic play intervention in reducing perioperative anxiety, negative behaviors, and postoperative pain in children undergoing elective surgery: a systematic review. Pain Manag Nurs. 2015 Jun;16(3):425-39. doi: 10.1016/j.pmn.2014.08.011.
- Background: PubMed 23991679He HG, Zhu L, Li HC, Wang W, Vehvilainen-Julkunen K, Chan SW. A randomized controlled trial of the effectiveness of a therapeutic play intervention on outcomes of children undergoing inpatient elective surgery: study protocol. J Adv Nurs. 2014 Feb;70(2):431-42. doi: 10.1111/jan.12234. Epub 2013 Aug 29.
- Background: PubMed 15690267Chhabra A, Pandey R, Khandelwal M, Subramaniam R, Gupta S. Anesthetic techniques and postoperative emesis in pediatric strabismus surgery. Reg Anesth Pain Med. 2005 Jan-Feb;30(1):43-7. doi: 10.1016/j.rapm.2004.08.023.
- Individual participant dataSharing planned: No
Related trials for Pain
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
Recruiting
Empowered Relief® for Cancer Survivors With Chronic Pain
Chronic Pain Due to Cancer, Pain Catastrophizing
RecruitingPhase 4
ESP Blocks for Posterior Spinal Fusion
Postoperative Pain
RecruitingObservational study
Pain Phenotypes in Individuals With Multiple Sclerosis
Multiple Sclerosis, Chronic Pain
Not yet recruiting
Effects of Hip Hinge Exercises on Pain, Range of Motion and Functional Disability in Non-specific Low Back Pain.
Low Back Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Hasima Hajdini, BSN principal investigator
St. Louis Children's Hospital
Charles Schrock, MD study director
Washington University School of Medicine
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Hydromorphone and Fentanyl in people with Pain and Nausea, run by St. Louis Children's Hospital at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 3 Jun 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Lisa Steurer, Phd(c) (314-608-2249, lmi8177@bjc.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in pain measured by the rFLACC scale (time frame: every 15 minutes for 2 hours and 24 hours after discharge). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02789969, which also lists 9 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2016.